Place de la gemcitabine dans le traitement des autres tumeurs malignes = The role of gemcitabine in other malignant tumoursCLIPPE, Christine; LIGNEAU, Blandine; TRILLET-LENOIR, Véronique et al.Bulletin du cancer. 2002, Vol 89, pp S120-S122, issn 0007-4551, NSArticle

Nouvelles thérapeutiques ciblées en oncologie = Targeted therapies in oncologyFOURNEL-FEDERICO, Cécile; YOU, Benoit; TRILLET-LENOIR, Véronique et al.La Revue du praticien (Paris). 2007, Vol 57, Num 19, pp 2093-2098, issn 0035-2640, 6 p.Article

Traitement des cancers: Chirurgie, radiothérapie, chimiothérapie, hormonothérapie. La décision thérapeutique multidisciplinaire et l'information du malade = Treatment of cancer: surgery, radiotherapy, chemotherapy, hormonal therapy. Multidisciplinary therapeutic decision making and informing the patientCLIPPE, Christine; TRILLET-LENOIR, Véronique; FREYER, Gilles et al.La Revue du praticien (Paris). 2003, Vol 53, Num 2, pp 187-198, issn 0035-2640, 12 p.Article

Tumeur à cellules de la granulosa : revue de la littérature = Granulosa cell tumour : review of the literatureBOMPAS, Emmanuelle; FREYER, Gilles; VITREY, Danielle et al.Bulletin du cancer. 2000, Vol 87, Num 10, pp 709-714, issn 0007-4551Article

Opinion des médecins sur la mise en oeuvre des recommandations pour la pratique clinique en oncologie digestive = Physicians' opinions about the implementation of clinical practice guidelines for gastrointestinal oncologyDUCLOS, Antoine; TRILLET-LENOIR, Véronique; CHAUVIN, Franck et al.La Presse médicale (1983). 2005, Vol 34, Num 12, pp 851-855, issn 0755-4982, 5 p.Article

Les principes généraux de l'effet-dose = Introduction to the principles of chemotherapy dose intensityBORG, Christophe; TRILLET-LENOIR, Véronique.Bulletin du cancer. 2001, Vol 88, Num 9, pp 833-834, issn 0007-4551Article

Oral vinorelbine : Role in the management of metastatic breast cancerAAPRO, Matti S; CONTE, Pierfranco; GONZALEZ, Emilio Esteban et al.Drugs (Basel). 2007, Vol 67, Num 5, pp 657-667, issn 0012-6667, 11 p.Article

Lhermitte sign and urinary retention: Atypical presentation of oxaliplatin neurotoxicity in four patientsTAIEB, Sarah; TRILLET-LENOIR, Véronique; RAMBAUD, Loïc et al.Cancer. 2002, Vol 94, Num 9, pp 2434-2440, issn 0008-543XArticle

Bilan d'activité cancérologique 2001-2002 des centres hospitaliers régionaux et universitaires de France à partir des données du PMSI = An overview of the 2001-2002 cancer activity in the 30 French Regional and University Hospitals, based on PMSI dataTHEIS, Didier; GILLERON, Véronique; SCHOTT, Anne-Marie et al.Bulletin du cancer. 2007, Vol 94, Num 10, pp 915-922, issn 0007-4551, 8 p.Article

Oncogériatrie: quelle réalité aujourd'hui? : Gériatrie = Oncogeriatrics' reality todayFALANDRY, Claire; FILBET, Marilène; MAGNET, Marc et al.Medecine palliative. 2011, Vol 10, Num 5, pp 223-229, issn 1636-6522, 7 p.Article

Pharmacokinetically Based Estimation of Patient Compliance with Oral Anticancer Chemotherapies In Silico EvaluationHENIN, Emilie; TOD, Michel; TRILLET-LENOIR, Véronique et al.Clinical pharmacokinetics. 2009, Vol 48, Num 6, pp 359-369, issn 0312-5963, 11 p.Article

Intensification thérapeutique des carcinomes bronchopulmonaires à petites cellules = Dose intensity of chemotherapy in small-cell lung carcinomaBORG, Christophe; LIGNEAU, Blandine; TRILLET-LENOIR, Véronique et al.Bulletin du cancer. 2001, Vol 88, Num 9, pp 863-870, issn 0007-4551Article

Reflexions from the experience of the french CLEOPATRE program and concerns about the status of clinical research on small cell lung cancerTRILLET-LENOIR, Veronique; LOTZ, J. P; LE CESNE, A et al.Lung cancer. 2001, Vol 33, Num 2-3, pp 303-307, issn 0169-5002Article

Protein Abundance of Class III Beta-tubulin but Not Δ2-Alpha-Tubulin or Tau is Related to Paclitaxel Response in Carcinomas of Unknown Primary SiteSEVE, Pascal; REIMAN, Tony; ISAAC, Sylvie et al.Anticancer research. 2008, Vol 28, Num 2B, pp 1161-1167, issn 0250-7005, 7 p.Article

Disseminated porokeratosis transiently healed by cancer chemotherapyBRETON, Anne Laure; PRALONG, Pauline; TRILLET-LENOIR, Véronique et al.EJD. European journal of dermatology. 2014, Vol 24, Num 2, pp 260-261, issn 1167-1122, 2 p.Article

Tumeurs malignes primitives du péritoine : étude d'une série de huit cas et revue de la littérature = Primary peritoneal tumors : report on a series of eight cases and review of the literatureCLIPPE, Christine; FREYER, Gilles; BIZOLLON, Marie-Hélène et al.Bulletin du cancer. 2002, Vol 89, Num 4, pp 430-436, issn 0007-4551Article

Addition of oxaliplatin to continuous fluorouracil, L-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 Phase I trialFREYER, Gilles; BOSSARD, Nadine; ROMESTAING, Pascale et al.Journal of clinical oncology. 2001, Vol 19, Num 9, pp 2433-2438, issn 0732-183XArticle

Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicityELIAS CHALOUHI, Gihad; GOLFIER, François; SOIGNON, Pauline et al.American journal of obstetrics and gynecology. 2009, Vol 200, Num 6, pp 643-645, issn 0002-9378, 3 p.Article

Méthodes d'évaluation médico-économique : applications à la cancérologie = Methodology of economic assessment: example in oncologyJAISSON-HOT, Isabelle; SCHOTT, Anne-Marie; CLIPPE, Christine et al.Bulletin du cancer. 2003, Vol 90, Num 11, pp 939-945, issn 0007-4551, 7 p.Article

The prognostic value of etoposide area under the curve (AUC) at first chemotherapy cycle in small cell lung cancer patients : a multicenter study of the groupe Lyon-Saint-Etienne d'Oncologie Thoracique (GLOT)FREYER, Gilles; LIGNEAU, Blandine; TRILLET-LENOIR, Véronique et al.Lung cancer. 2001, Vol 31, Num 2-3, pp 247-256, issn 0169-5002Article

Improving Cancer Patient Care with Combined Medication Error Reviews and Morbidity and Mortality ConferencesRANCHON, Florence; YOU, Benoît; TRILLET-LENOIR, Véronique et al.Chemotherapy (Basel). 2013, Vol 59, Num 5, pp 330-337, issn 0009-3157, 8 p.Article

First epidemiologic data from the french trophoblastic disease reference centerGOLFIER, Francois; RAUDRANT, Daniel; FRAPPART, Lucien et al.American journal of obstetrics and gynecology. 2007, Vol 196, Num 2, pp 172-173, issn 0002-9378, 2 p.Article

Intérêt de l'utilisation du PMSI pour l'analyse d'activité cancérologique d'une structure de soins multidisciplinaire : l'expérience de la coordination de cancérologie des Hospices Civils de Lyon = Usefulness of the French DRG based information system (PMSI) in the measurement of cancer activity in a multidisciplinary hospital: the Hospices Civils de LyonSCHOTT, Anne-Marie; HAJRI, Touria; COLIN, Cyrille et al.Bulletin du cancer. 2002, Vol 89, Num 11, pp 969-973, issn 0007-4551, 5 p.Article

Quelles approches médico-économiques choisir pour l'évaluation de l'impact des molécules coûteuses en cancérologie ? Le modèle de l'Herceptin® dans le cancer du sein métastatique = Which medico-economic approaches must be taken to evaluate the impact of costly molecules in oncology? The model of Herceptin® in the breast metastatic cancerGANNE, Christell; TRILLET-LENOIR, Véronique; JAISSON-HOT, Isabelle et al.Bulletin du cancer. 2003, Vol 90, Num 11, pp 955-960, issn 0007-4551, 6 p.Article

Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients : Results of a multicentre studyFREYER, Gilles; TRANCHAND, Brigitte; GIRARD, Pascal et al.British journal of clinical pharmacology. 2000, Vol 50, Num 4, pp 315-324, issn 0306-5251Article